Send the following on WhatsApp
Continue to ChatJAMA:FDA 於 2018-2021 年核准藥物,10% 樞紐試驗未達主要療效指標 https://geneonline.news/surrogate-endpoint-fda-approval/?variant=zh-cn
JAMA:FDA 於 2018-2021 年核准藥物,10% 樞紐試驗未達主要療效指標 https://geneonline.news/surrogate-endpoint-fda-approval/?variant=zh-cn